Isabella Sudano
Overview
Explore the profile of Isabella Sudano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rossi V, Laptseva N, Nebunu D, Haider T, Nagele M, Ruschitzka F, et al.
Int J Cardiol
. 2023 Nov;
398:131592.
PMID: 37979794
Background: Cardiovascular (CV) risk factors and CV diseases, in particular heart failure, are strongly associated with impaired microvascular retinal endothelial function. Whether atrial fibrillation (AF) contributes to vascular dysfunction is...
12.
Gruber S, Stasi E, Pion A, Steiner R, Erlic Z, Bornstein S, et al.
Horm Metab Res
. 2023 Nov;
56(4):300-307.
PMID: 37924818
Hypokalemia plays an important role in the diagnosis and management of primary aldosteronism (PA). While the hypokalemic variant of the disease accounts for about one third of all cases, little...
13.
Rossi V, Nebunu D, Haider T, Laptseva N, Naegele M, Ruschitzka F, et al.
ESC Heart Fail
. 2023 Sep;
10(6):3419-3429.
PMID: 37697706
Aims: Epicardial adipose tissue (EAT) is a metabolically highly active tissue modulating numerous pathophysiological processes. The aim of this study was to investigate the association between EAT thickness and endothelial...
14.
Sudano I, Suter P, Beuschlein F
Blood Press
. 2023 Jun;
32(1):2224898.
PMID: 37334480
In secondary hypertension, elevated blood pressure is caused by a known and/or potentially treatable underlying disease.Although the prevalence of secondary hypertension depends on the patient population and the thoroughness of...
15.
Laptseva N, Rossi V, Sudano I, Schwotzer R, Ruschitzka F, Flammer A, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048664
Amyloidosis is a systemic disease characterized by extracellular deposits of insoluble amyloid in various tissues and organs. Cardiac amyloidosis is a frequent feature of the disease, causing a progressive, restrictive...
16.
Barbato E, Azizi M, Schmieder R, Lauder L, Bohm M, Brouwers S, et al.
Eur Heart J
. 2023 Feb;
44(15):1313-1330.
PMID: 36790101
Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several high-quality studies, including randomised, sham-controlled trials on catheter-based...
17.
Barbato E, Azizi M, Schmieder R, Lauder L, Bohm M, Brouwers S, et al.
EuroIntervention
. 2023 Feb;
18(15):1227-1243.
PMID: 36789560
Since the publication of the 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several high-quality studies, including randomised, sham-controlled trials on catheter-based...
18.
Endocrine hormone imbalance in heart failure with reduced ejection fraction: A cross-sectional study
Nagele M, Barthelmes J, Kreysing L, Haider T, Nebunu D, Ruschitzka F, et al.
Health Sci Rep
. 2022 Nov;
5(6):e880.
PMID: 36320653
Background And Aims: Sustained neurohormonal activation plays a central role in the progression of heart failure (HF). Other endocrine axes may also be affected. It was the aim of this...
19.
Damianaki A, Wang W, Beaney T, Burkard T, Sudano I, Burnier M, et al.
Eur Heart J Suppl
. 2022 Oct;
24(Suppl F):F38-F40.
PMID: 36225275
May Measurement Month (MMM) is an international screening campaign for arterial hypertension initiated by the International Society of Hypertension and endorsed by the World Hypertension League. Its aim is to...
20.
Reel P, Reel S, van Kralingen J, Langton K, Lang K, Erlic Z, et al.
EBioMedicine
. 2022 Sep;
84:104276.
PMID: 36179553
Background: Arterial hypertension is a major cardiovascular risk factor. Identification of secondary hypertension in its various forms is key to preventing and targeting treatment of cardiovascular complications. Simplified diagnostic tests...